ATE479696T1 - Verbessertes verfahren zur behandlung von cystischer fibrose - Google Patents

Verbessertes verfahren zur behandlung von cystischer fibrose

Info

Publication number
ATE479696T1
ATE479696T1 AT07747401T AT07747401T ATE479696T1 AT E479696 T1 ATE479696 T1 AT E479696T1 AT 07747401 T AT07747401 T AT 07747401T AT 07747401 T AT07747401 T AT 07747401T AT E479696 T1 ATE479696 T1 AT E479696T1
Authority
AT
Austria
Prior art keywords
cystic fibrosis
improved method
found
treating cystic
membrane bilayer
Prior art date
Application number
AT07747401T
Other languages
English (en)
Inventor
Johannes Maria Franciscus Gerardus Aerts
Rolf Gabriel Boot
Original Assignee
Amc Amsterdam
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amc Amsterdam filed Critical Amc Amsterdam
Application granted granted Critical
Publication of ATE479696T1 publication Critical patent/ATE479696T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
AT07747401T 2006-04-24 2007-04-24 Verbessertes verfahren zur behandlung von cystischer fibrose ATE479696T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79408806P 2006-04-24 2006-04-24
PCT/NL2007/050177 WO2007123403A1 (en) 2006-04-24 2007-04-24 Improved treatment of cystic fibrosis

Publications (1)

Publication Number Publication Date
ATE479696T1 true ATE479696T1 (de) 2010-09-15

Family

ID=38283020

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07747401T ATE479696T1 (de) 2006-04-24 2007-04-24 Verbessertes verfahren zur behandlung von cystischer fibrose

Country Status (10)

Country Link
US (1) US8410081B2 (de)
EP (1) EP2010551B1 (de)
JP (1) JP2009538276A (de)
CN (1) CN101479288B (de)
AT (1) ATE479696T1 (de)
AU (1) AU2007241622A1 (de)
BR (1) BRPI0710883A2 (de)
CA (1) CA2650311A1 (de)
DE (1) DE602007008870D1 (de)
WO (1) WO2007123403A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0712494D0 (en) 2007-06-27 2007-08-08 Isis Innovation Substrate reduction therapy
ES2579628T3 (es) 2009-02-23 2016-08-12 Emergent Virology Llc Iminoazúcares y métodos de tratamiento de enfermedades virales
JP5951996B2 (ja) * 2009-02-24 2016-07-13 ユナイテッド セラピューティクス コーポレーション イミノ糖及びアレナウイルス感染症を治療する方法
JP5634510B2 (ja) 2009-06-12 2014-12-03 ユナイテッド セラピューティクス コーポレイション イミノ糖ならびにブニヤウイルスおよびトガウイルス疾患を治療する方法
CN102625796B (zh) * 2009-09-04 2015-03-11 联合治疗公司 治疗正粘病毒感染的方法
WO2011028781A1 (en) * 2009-09-04 2011-03-10 United Therapeutics Corporation Methods of treating poxviral infections
ES2527623T3 (es) * 2009-09-04 2015-01-27 United Therapeutics Corporation Iminoazúcares para su uso en el tratamiento de enfermedades por filovirus
GB201000499D0 (en) 2010-01-13 2010-03-03 Fleet George W J Treatment of cystic fibrosis
WO2011095772A2 (en) 2010-02-04 2011-08-11 Summit Corporation Plc Novel iminosugar therapeutics
GB201006434D0 (en) 2010-04-19 2010-06-02 Summit Corp Plc Novel iminosugar combinations
DK2753346T3 (da) 2011-09-07 2020-05-25 Sinai School Medicine Ceramidase og celledifferentiering
HUE051020T2 (hu) * 2012-06-01 2021-01-28 Icahn School Med Mount Sinai A ceramid szintjei a fertõzések kezelésében és megelõzésében
EP2929346A1 (de) * 2012-12-05 2015-10-14 Institut National de la Santé et de la Recherche Médicale (INSERM) Diagnose von zystischer fibrose
ES2739811T3 (es) 2013-03-14 2020-02-04 Icahn School Med Mount Sinai Composiciones terapéuticas de ceramidasa ácida y métodos de fabricación y uso de ellas
EP3442514B1 (de) 2016-04-11 2021-06-16 Spedding Research Solutions Inhibitoren des glucosylceramidabbaus bei der behandlung von erkrankungen der motorischen einheiten
EA201992807A1 (ru) 2017-06-01 2020-05-20 Идорсия Фармасьютиклз Лтд Кристаллическая форма n-бутилдеоксигалактоноджиримицина
EP4305176A1 (de) * 2021-03-12 2024-01-17 Excepgen Inc. Systeme und verfahren zur proteinexpression

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0912179B1 (de) 1996-07-15 2006-04-12 MacroZyme DNM B.V. Deoxynojirimycin derivate und ihre verwendung als glukosesylceramidase-inhibitoren
WO2001002586A1 (en) * 1999-06-29 2001-01-11 Mcgill University Human alpha 1,2-mannosidase
EP1528056A1 (de) * 2003-10-29 2005-05-04 Academisch Ziekenhuis bij de Universiteit van Amsterdam Deoxynojirimycin Derivate und ihre Verwendung als Glukosesylceramidase-Inhibitoren
FR2861991B1 (fr) * 2003-11-07 2008-01-18 Centre Nat Rech Scient Utilisation d'inhibiteurs de glucosidase pour une therapie de la mucoviscidose
US20090111812A1 (en) 2004-06-14 2009-04-30 Musc Foundation For Research Development Methods for treating inflammatory disorders
NZ565953A (en) * 2005-07-27 2012-01-12 Univ Florida Small compounds that correct protein misfolding and uses thereof

Also Published As

Publication number Publication date
AU2007241622A1 (en) 2007-11-01
CN101479288B (zh) 2012-06-27
EP2010551B1 (de) 2010-09-01
AU2007241622A8 (en) 2008-12-04
EP2010551A1 (de) 2009-01-07
WO2007123403A1 (en) 2007-11-01
BRPI0710883A2 (pt) 2011-08-09
US20090186862A1 (en) 2009-07-23
CN101479288A (zh) 2009-07-08
US8410081B2 (en) 2013-04-02
DE602007008870D1 (de) 2010-10-14
CA2650311A1 (en) 2007-11-01
JP2009538276A (ja) 2009-11-05

Similar Documents

Publication Publication Date Title
ATE479696T1 (de) Verbessertes verfahren zur behandlung von cystischer fibrose
Franklin et al. The prevalence of epigenetic mechanisms in the regulation of cognitive functions and behaviour
IL185428A0 (en) 2-[isoquinolin-3- carbonyl) amino] - propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis
MXPA05003493A (es) Metodos para generar y seleccionar proteasas con especificidad alterada.
NO20065864L (no) Femleddete heterosykler anvendelige som serinproteaseinhibitorer
DE602005006938D1 (de) Gebrauchslimitierendes elektronisches Schlüsselsystem für Plasmagerät zur Behandlung von Gewebeoberflächen
EA200401043A1 (ru) Лечение доброкачественной гиперплазии простаты селективным модулятором рецептора андрогенов ( sarm )
ATE455574T1 (de) Prä-exzitations-pacing zur behandlung von hypertonie
MX342128B (es) Compuestos farmaceuticos.
NO20082834L (no) 2-(fenyl eller heterosyklisk)-1H-fenantro[9,10-D]imidazoler som MPGES-1-inhibitorer
WO2011137320A3 (en) Small molecule inhibitors of usp1 deubiquitinating enzyme activity
BR0007778A (pt) Peptidila cetonas heterocìclicas úteis como inibidores de triptase
BRPI0510817A (pt) protease, uso de uma protease, composição farmacêutica, e, método para o tratamento de uma doença
GB0317466D0 (en) Use
CY1109363T1 (el) Υδροξαμικες ενωσεις ως θεραπευτικοι παραγοντες
DE602004020263D1 (de) Amino-substituierte diaryläa,dücyclohepten- analoga als muscarinische agonisten und verfahren zur behandlung von neuropsychiatrischen erkrankungen
DE602004004665D1 (en) Acetylenderivate als inhibitoren von histondeacetylase
NO20071019L (no) Quinazolinderivater og deres anvendelse ved behandling av trombocytemi
SG164371A1 (en) Inhibitors of microsomal triglyceride transfer protein and apo-b secretion
ATE423561T1 (de) Verwendung von glucosidase-hemmern zur behandlung von mukoviszidose
DE112004000961D2 (de) Verwendung von Wirksubstanzen zur Vorbeugung oder Behandlung von Viruserkrankungen sowie Testsystem zum Auffinden solcher Wirksubstanzen
DE602004017283D1 (de) Verfahren zur behandlung von schwerer herzinsuffizienz und medikament dafür
WO2003099202A3 (en) Beta-secretase inhibitors
ATE469168T1 (de) Peptide zur transglutaminase-hemmung
NO20071466L (no) 3-substituerte-5- og 6-aminoalkyl indol-2-karboksylsyreamider og relaterte analoger som inhibitorer av kaseinkinase IE

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties